RECOMBINANT POXVIRUS BASED VACCINE AGAINST SARS-CoV-2 VIRUS 2022.05.29 23:18 US Patent Application for RECOMBINANT POXVIRUS BASED VACCINE AGAINST SARS-CoV-2 VIRUS Patent Applica